INFORMAZIONI SU QUESTO PODCAST 🔗

Conduttori:
Frequenza di aggiornamento:
monthly
Durata media dell'audio:
38 minutes
Interviste agli ospiti
Inglese
Stati Uniti
6 episodi
da 09 Maggio 2024
episodic

ULTIMO EPISODIO 🔗

This is officially the end of Season 1. Thanks everyone, see you in 2025 for Season 2! Thanks to our monthly supporters Annette B. Rosemary Anderson

CERCA TRA GLI EPISODI PASSATI

Cerca gli episodi passati di Decoding NF.

EPISODI PRECEDENTI

My guest for this episode is Dr. Tessa Hadlock, a renowned facial plastic surgeon and expert in facial nerve disorders. Dr. Hadlock discusses her pioneering work in facial paralysis treatments, specifically focusing on conditions related to Neurofibromatosis Type 2 (NF2). The conversation delves in…
In this episode, my guest is Dr. David Gutmann, a leading neurologist specializing in Neurofibromatosis Type 1 (NF1). The conversation delves into Dr. Gutmann's groundbreaking research on the NF1 protein neurofibromin and its role in downregulating the RAS/RAF/MAPK cell signaling pathway. We explor…
My guest this episode is John Manth, father of Leah Manth, who was diagnosed with Neurofibromatosis Type 2 (NF2-SWN) in 2007. John discusses their family's journey in seeking treatments and a cure for NF2, his extensive involvement in various NF organizations, and the impactful role of their servic…
This episode features Dr. Frank Buono, an Associate Research Scientist and Lecturer at the Yale School of Medicine, discussing his research on utilizing digital technologies to assist with treatment for individuals with rare diseases like neurofibromatosis (NF), with a focus on managing chronic pai…

Introduction

· trascrizione
Welcome to Decoding NF! This is just a brief introduction to the show. Thanks to our monthly supporters Annette B. Rosemary Anderson
Hai visto tutti gli episodi di questo podcast
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Shane Smith, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.